Sopharma AD (WSE:SPH)
Poland flag Poland · Delayed Price · Currency is PLN
13.45
-1.45 (-9.73%)
Jun 17, 2025, 6:52 PM CET

Sopharma AD Revenue

Sopharma AD had revenue of 644.07M BGN in the quarter ending March 31, 2025, with 25.43% growth. This brings the company's revenue in the last twelve months to 2.27B, up 17.44% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.

Revenue (ttm)
2.27B BGN
Revenue Growth
+17.44%
P/S Ratio
0.50
Revenue / Employee
405.44K BGN
Employees
5,599
Market Cap
2.42B PLN

Revenue Chart

* This company reports financials in BGN.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.14B250.64M13.27%
Dec 31, 20231.89B217.31M13.00%
Dec 31, 20221.67B60.17M3.73%
Dec 31, 20211.61B165.21M11.42%
Dec 31, 20201.45B158.02M12.27%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.82B
Synektik Spólka Akcyjna 593.62M
Voxel 556.98M
Celon Pharma 215.11M
Ryvu Therapeutics 97.57M
Centrum Medyczne ENEL-MED 762.83M
Selvita 359.79M
EMC Instytut Medyczny 836.81M
Revenue Rankings